Three Arch Associates IV LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Three Arch Associates IV LP
CIK #0001276986
EDGAR Form CIK 2011 - 2026
3 [0001276986]
4 [0001276986]
Form 3/4/5 Subject 2011 - 2026
Three Arch Associates IV LP
Three Arch Partners IV LP
Jaeger Wilfred E
Talphera Inc
Three Arch Associates III LP
Wan Mark A
Three Arch Partners III LP
Three Arch Management IV LLC
Concert Pharmaceuticals Inc
Nevro Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Talphera Inc ACRX
Common Stock
2018-05-21 Other 5,713,569
Talphera Inc ACRX
Common Stock
2018-05-21 Other 179,962
Talphera Inc ACRX
Common Stock
2018-05-21 Other 3,347,357
Talphera Inc ACRX
Common Stock
2018-05-21 Other 126,153
Concert Pharmaceuticals Inc CNCE
Common Stock
2014-11-18 Sell 5,400 $12.29 66,366
Concert Pharmaceuticals Inc CNCE
Common Stock
2014-11-18 Sell 244,600 $12.29 3,006,134
Nevro Corp NVRO
Common Stock
2014-11-12 Conversion 28,090
Nevro Corp NVRO
Common Stock
2014-11-12 Conversion 204,076
Nevro Corp NVRO
Common Stock
2014-11-12 Conversion 682,475
Nevro Corp NVRO
Common Stock
2014-11-12 Conversion 1,272,187
Nevro Corp NVRO
Series C Preferred Stock · derivative
2014-11-12 Conversion 4,506
Nevro Corp NVRO
Series B Preferred Stock · derivative
2014-11-12 Conversion 15,069
Nevro Corp NVRO
Series A Preferred Stock · derivative
2014-11-12 Conversion 28,090
Nevro Corp NVRO
Series C Preferred Stock · derivative
2014-11-12 Conversion 204,076
Nevro Corp NVRO
Series A Preferred Stock · derivative
2014-11-12 Conversion 1,272,187
Nevro Corp NVRO
Series B Preferred Stock · derivative
2014-11-12 Conversion 682,475
Nevro Corp NVRO
Common Stock
2014-11-12 Conversion 15,069
Nevro Corp NVRO
Common Stock
2014-11-12 Conversion 4,506
Concert Pharmaceuticals Inc CNCE
Series A Convertible Preferred Stock · derivative
2014-02-19 Conversion 1,467,595 $0.00
Concert Pharmaceuticals Inc CNCE
Series C Convertible Preferred Stock · derivative
2014-02-19 Conversion 391,359 $0.00
showing 20 of 34 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com